Efficacy End Points and Dose Analysis of Food and Drug Administration-Approved Novel Drugs in 2020

BACKGROUND: During 2020, the Food and Drug Administration approved 53 novel drugs. OBJECTIVE: Biomarkers, surrogate endpoints and dosing regimens used in early and pivotal clinical stages are evaluated. METHODS: Information on various efficacy end points of 2020 Food and Drug Administration approved...

Descripción completa

Detalles Bibliográficos
Autor principal: Tang, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310132/
https://www.ncbi.nlm.nih.gov/pubmed/35899102
http://dx.doi.org/10.1016/j.curtheres.2022.100680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310132/
https://www.ncbi.nlm.nih.gov/pubmed/35899102
http://dx.doi.org/10.1016/j.curtheres.2022.100680

Ejemplares similares